The Food and Drug Administration (“FDA”) said on Thursday that they will seek to pull the common ingredient phenylephrine off ...

This follows an extensive review that found the drug ineffective for treating nasal congestion. Oral phenylephrine, widely ...

AstraZeneca (GB:AZN) has released an update. AstraZeneca’s Tezspire has shown promising results in the Phase III WAYPOINT trial, ...

If you are unfortunate enough to come down with sickness, Doctor Sooj said: “Stay well hydrated, as this can soothe your ...

(Alliance News) - AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps.

The US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.

showed a "statistically significant and clinically meaningful reduction in the size of nasal polyps and reduced nasal ...

The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove ...

Amgen (NASDAQ:AMGN) and AstraZeneca today announced positive top-line results from the Phase 3 WAYPOINT trial in patients ...

I take 5 mg of Crestor and a multivitamin daily. I recently took a generic 12-hour, maximum-strength nasal decongestant to ...

maximum-strength nasal decongestant to manage typical sinus pressure and congestion. Within an hour of taking the medication, I noticed a dull and consistent pain in both testicles, which lasted for ...